Small Molecules
1 August 2016
Chi-Med and AstraZeneca Amend Co-development Agreement to Accelerate Savolitinib Global Development Program27 July 2016
TauRx Reports First Phase 3 Results for LMTX®27 July 2016
Neurovance Announces Positive Centanafadine Phase 2b Results for Adult ADHD, and Plans for Phase 3 Trials26 July 2016
Tokai Pharmaceuticals Announces Clinical UpdateNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports